AU2003264417A1 - Crystal of 2-amino-6-(4-methoxyphenylthio)-9-(2-(phosphonomethoxy)ethyl)purine bis(2,2,2-trifluoroethyl) ester - Google Patents

Crystal of 2-amino-6-(4-methoxyphenylthio)-9-(2-(phosphonomethoxy)ethyl)purine bis(2,2,2-trifluoroethyl) ester

Info

Publication number
AU2003264417A1
AU2003264417A1 AU2003264417A AU2003264417A AU2003264417A1 AU 2003264417 A1 AU2003264417 A1 AU 2003264417A1 AU 2003264417 A AU2003264417 A AU 2003264417A AU 2003264417 A AU2003264417 A AU 2003264417A AU 2003264417 A1 AU2003264417 A1 AU 2003264417A1
Authority
AU
Australia
Prior art keywords
phosphonomethoxy
methoxyphenylthio
trifluoroethyl
ester
ethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003264417A
Inventor
Haruki Inokawa
Toshio Masunaga
Kouichi Sekiya
Tadashi Shirasaka
Masaru Ubasawa
Hiroyuki Yamada
Katsuyoshi Yoshizawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Pharma Corp
Original Assignee
Mitsubishi Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Pharma Corp filed Critical Mitsubishi Pharma Corp
Publication of AU2003264417A1 publication Critical patent/AU2003264417A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/24—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one nitrogen and one sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65616—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
AU2003264417A 2002-09-13 2003-09-12 Crystal of 2-amino-6-(4-methoxyphenylthio)-9-(2-(phosphonomethoxy)ethyl)purine bis(2,2,2-trifluoroethyl) ester Abandoned AU2003264417A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2002268122 2002-09-13
JP2002-268122 2002-09-13
JP2002-332164 2002-11-15
JP2002332164 2002-11-15
PCT/JP2003/011690 WO2004024743A1 (en) 2002-09-13 2003-09-12 Crystal of 2-amino-6-(4-methoxyphenylthio)-9-[2-(phosphonomethoxy)ethyl]purine bis(2,2,2-trifluoroethyl) ester

Publications (1)

Publication Number Publication Date
AU2003264417A1 true AU2003264417A1 (en) 2004-04-30

Family

ID=31996171

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003264417A Abandoned AU2003264417A1 (en) 2002-09-13 2003-09-12 Crystal of 2-amino-6-(4-methoxyphenylthio)-9-(2-(phosphonomethoxy)ethyl)purine bis(2,2,2-trifluoroethyl) ester

Country Status (4)

Country Link
KR (1) KR20040024521A (en)
AU (1) AU2003264417A1 (en)
TW (1) TW200410972A (en)
WO (1) WO2004024743A1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW369536B (en) * 1996-01-18 1999-09-11 Mitsubishi Chem Corp Phosphonate nucleotide compounds

Also Published As

Publication number Publication date
KR20040024521A (en) 2004-03-20
TW200410972A (en) 2004-07-01
WO2004024743A1 (en) 2004-03-25

Similar Documents

Publication Publication Date Title
AU2003248651A1 (en) Optical metrology of single features
AU2003202957A1 (en) Optical imaging of nanostructured substrates
AU2003261290A1 (en) Rear projection display
AU2003219894A1 (en) Enhancements to optical flat panel displays
AU2003299015A1 (en) Beam plasma source
AU2002322651A1 (en) Optical film having microreplicated structures
AU2003223613A1 (en) Chemiluminescent light source using visible light for biotherapy
AU2003289264A1 (en) Mutant d-aminotransferase and process for producing optically active glutamic acid derivative using the same
AUPS285202A0 (en) Stand for flat panel display
AU2003239723A1 (en) Offset projection for slim rear projection displays
AU2003295138A1 (en) Optical waveguide
AU2003302035A1 (en) Formulations used for the treatment of substrate surfaces
AU2003201893A1 (en) Optical module
AU2003246548A1 (en) Optical device comprising an light source
AU2003222671A1 (en) Optical waveguide
AU2003210130A1 (en) Optical glass
AU2003209112A1 (en) Separated beam multiple degree of freedom interferometer
AU2003208056A1 (en) Optical glass
AU2002337338A1 (en) An optical light source
AU2003246422A1 (en) Optical device for the combination of light beams
AU2003224051A1 (en) Watersoluble prodrugs of propofol
AU2001290632A1 (en) Light source for use with scopes
AU2003264417A1 (en) Crystal of 2-amino-6-(4-methoxyphenylthio)-9-(2-(phosphonomethoxy)ethyl)purine bis(2,2,2-trifluoroethyl) ester
AU2003272920A1 (en) Optical receptacle
AU2003254472A1 (en) Connection to optical backplane

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase